{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AMPK", "IF1", "NAFLD", "Shenling Baizhu powder", "UCP2", "intestinal flora", "mitochondria", "short-chain fatty acid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37538846", "DateRevised": {"Year": "2023", "Month": "08", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "18"}], "Language": ["eng"], "ELocationID": ["1147067", "10.3389/fmicb.2023.1147067"], "Journal": {"ISSN": "1664-302X", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in microbiology", "ISOAbbreviation": "Front Microbiol"}, "ArticleTitle": "Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice.", "Pagination": {"StartPage": "1147067", "MedlinePgn": "1147067"}, "Abstract": {"AbstractText": ["Non-alcoholic fatty liver disease (NAFLD) is characterised by the excessive accumulation of triglycerides in the liver. Shenling Baizhu powder (SLBZP) is formulated from various natural medicinal plants that protect the liver and are used to treat intestinal diseases. SLBZP improves the symptoms of NAFLD. However, its mechanism of action remains unclear. Herein, we investigated the ameliorative effect of SLBZP on model mice with high-fat-diet (HFD)-induced NAFLD. Additionally, we evaluated the impact of SLBZP on the intestinal flora and its metabolites and mitochondrial energy metabolism in NAFLD.", "We used HFD to establish a mouse model of NAFLD. Different drug interventions were administered. We measured serum biochemical indices. Liver sections were visualised with hematoxylin-eosin and oil red O staining. <i>16S rDNA</i> amplicon sequencing technology was used to analyse the diversity and abundance of the intestinal flora. Short-chain fatty acids (SCFAs) in the intestinal contents were detected using GC-MS. Liver tissue was sampled to detect mitochondrial membrane functional indices. Western blotting was used to determine the levels of mitochondrial pathway-related proteins, namely, uncoupling protein 2 (UCP2), adenosine monophosphate-activated protein kinase (AMPK) and inhibitory factor 1 (IF1) of F1Fo ATP synthesis/hydrolase, in the liver.", "The spleen-invigorating classic recipe of SLBZP reduced liver lipid deposition in mice with HFD-induced NAFLD. Additionally, SCFAs produced by intestinal flora metabolism regulated the UCP2/AMPK/IF1 signalling pathway involved in liver mitochondrial energy metabolism to improve the liver mitochondrial membrane permeability, respiratory state and oxidative phosphorylation efficiency of mice with NAFLD. Finally, SLBZP increased the liver ATP level.", "Our results suggest that the therapeutic effect of SLBZP on NAFLD is related to the regulation of hepatic mitochondrial energy metabolism by intestinal flora and its metabolites and is possibly associated with the UCP2/AMPK/IF1 signalling pathway."], "CopyrightInformation": "Copyright \u00a9 2023 Yao, Guo, Du, Hong, Zhu, Feng, Hou and Shi."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, China."}, {"Identifier": [], "Affiliation": "Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Kunming, China."}], "LastName": "Yao", "ForeName": "Zheng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}, {"Identifier": [], "Affiliation": "Dongtai City Hospital of Traditional Chinese Medicine, Dongtai, China."}], "LastName": "Guo", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}, {"Identifier": [], "Affiliation": "Heilongjiang Provincial Hospital of Traditional Chinese Medicine, Harbin, China."}], "LastName": "Du", "ForeName": "Bing", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}, {"Identifier": [], "Affiliation": "Wuhan Special Service Recuperation Center, Wuhan, China."}], "LastName": "Hong", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}], "LastName": "Zhu", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}], "LastName": "Feng", "ForeName": "Xiaoyi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}], "LastName": "Hou", "ForeName": "Yuanlu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Microcosmic Syndrome Differentiation, Education Department of Yunnan, Yunnan University of Chinese Medicine, Kunming, China."}, {"Identifier": [], "Affiliation": "Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Kunming, China."}], "LastName": "Shi", "ForeName": "Anhua", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Microbiol", "NlmUniqueID": "101548977", "ISSNLinking": "1664-302X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmadi S., Razazan A., Nagpal R., Jain S., Wang B., Mishra S. P., et al. . (2020). Metformin reduces aging-related leaky gut and improves cognitive function by beneficially modulating gut microbiome/goblet cell/mucin axis. J. Gerontol. A 75, e9\u2013e21. doi: 10.1093/gerona/glaa056, PMID:", "ArticleIdList": ["10.1093/gerona/glaa056", "PMC7302182", "32129462"]}, {"Citation": "Al-Lahham S. H., Roelofsen H., Priebe M., Weening D., Dijkstra M., Hoek A., et al. . (2010). Regulation of adipokine production in human adipose tissue by propionic acid. Eur. J. Clin. Investig. 40, 401\u2013407. doi: 10.1111/j.1365-2362.2010.02278.x, PMID:", "ArticleIdList": ["10.1111/j.1365-2362.2010.02278.x", "20353437"]}, {"Citation": "Al-Lahham S., Roelofsen H., Rezaee F., Weening D., Hoek A., Vonk R., et al. . (2012). Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur. J. Clin. Investig. 42, 357\u2013364. doi: 10.1111/j.1365-2362.2011.02590.x, PMID:", "ArticleIdList": ["10.1111/j.1365-2362.2011.02590.x", "21913915"]}, {"Citation": "Andreyev A. Y., Kushnareva Y. E., Starkova N. N., Starkov A. A. (2020). Metabolic ROS signaling: to immunity and beyond. Biochemistry 85, 1650\u20131667. doi: 10.1134/s0006297920120160, PMID:", "ArticleIdList": ["10.1134/s0006297920120160", "PMC7768995", "33705302"]}, {"Citation": "Anji H., Shiping P., Rong X. (2003). Study on the anti-inflammatory effect of poria cocos polysaccharide. Pharmacol. Clin. Chin. Mater. Med. 03, 15\u201316. doi: 10.3969/j.issn.1001-859X.2003.03.009.Chinese", "ArticleIdList": ["10.3969/j.issn.1001-859X.2003.03.009.Chinese"]}, {"Citation": "Bailey C. J., Mynett K. J., Page T. (1994). Importance of the intestine as a site of metformin-stimulated glucose utilization. Br. J. Pharmacol. 112, 671\u2013675. doi: 10.1111/j.1476-5381.1994.tb13128.x", "ArticleIdList": ["10.1111/j.1476-5381.1994.tb13128.x", "PMC1910373", "8075887"]}, {"Citation": "Berggren A. M., Nyman E. M., Lundquist I., Bj\u00f6rck I. M. (1996). Influence of orally and rectally administered propionate on cholesterol and glucose metabolism in obese rats. Br. J. Nutr. 76, 287\u2013294. doi: 10.1079/bjn19960032, PMID:", "ArticleIdList": ["10.1079/bjn19960032", "8813902"]}, {"Citation": "Bian Yao H. W., Yao Z., et al. . (2014). Experimental research of Quzhi Ruangan prescription in effect of von Willebrand factor in rats with fatty liver caused by high fat. China Med. Herald 11, 4\u20136. doi: 10.3969/j.issn.1001-5256.2022.05.018.Chinese", "ArticleIdList": ["10.3969/j.issn.1001-5256.2022.05.018.Chinese"]}, {"Citation": "Bolger A. M., Lohse M., Usadel B. (2014). Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics 30, 2114\u20132120. doi: 10.1093/bioinformatics/btu170, PMID:", "ArticleIdList": ["10.1093/bioinformatics/btu170", "PMC4103590", "24695404"]}, {"Citation": "Bonora E., Cigolini M., Bosello O., Zancanaro C., Capretti L., Zavaroni I., et al. . (1984). Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects. Curr. Med. Res. Opin. 9, 47\u201351. doi: 10.1185/03007998409109558, PMID:", "ArticleIdList": ["10.1185/03007998409109558", "6373159"]}, {"Citation": "Brandt A., Hern\u00e1ndez-Arriaga A., Kehm R., S\u00e1nchez V., Jin C. J., Nier A., et al. . (2019). Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. Sci. Rep. 9:6668. doi: 10.1038/s41598-019-43228-0, PMID:", "ArticleIdList": ["10.1038/s41598-019-43228-0", "PMC6491483", "31040374"]}, {"Citation": "Bullon P., Marin-Aguilar F., Roman-Malo L. (2016). AMPK/mitochondria in metabolic diseases. Exp. Suppl. 107, 129\u2013152. doi: 10.1007/978-3-319-43589-3_6", "ArticleIdList": ["10.1007/978-3-319-43589-3_6", "27812979"]}, {"Citation": "Buzzetti E., Pinzani M., Tsochatzis E. A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038\u20131048. doi: 10.1016/j.metabol.2015.12.012", "ArticleIdList": ["10.1016/j.metabol.2015.12.012", "26823198"]}, {"Citation": "Chen M., Xie S., Dai W., Li J., Li J., Huang X., et al. . (2018). Applications and research progresses of Shenling Baizhu decoction in digestive system diseases. J. Liaoning Univ. Tradit. Chin. Med. 20, 164\u2013166. doi: 10.13194/j.issn.1673-842x.2018.10.042.Chinese", "ArticleIdList": ["10.13194/j.issn.1673-842x.2018.10.042.Chinese"]}, {"Citation": "Cheng Z., Hu M., Tao J., Yang H., Yan P., An G., et al. . (2019). The protective effects of Chinese yam polysaccharide against obesity-induced insulin resistance. J. Funct. Foods 55, 238\u2013247. doi: 10.1016/j.jff.2019.02.023", "ArticleIdList": ["10.1016/j.jff.2019.02.023"]}, {"Citation": "Cortez-Pinto H., Machado M. V. (2009). Uncoupling proteins and non-alcoholic fatty liver disease. J. Hepatol. 50, 857\u2013860. doi: 10.1016/j.jhep.2009.02.019", "ArticleIdList": ["10.1016/j.jhep.2009.02.019", "19328582"]}, {"Citation": "Deehan E. C., Yang C., Perez-Mu\u00f1oz M. E., Nguyen N. K., Cheng C. C., Triador L., et al. . (2020). Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell Host Microbe 27, 389\u2013404.e6. doi: 10.1016/j.chom.2020.01.006, PMID:", "ArticleIdList": ["10.1016/j.chom.2020.01.006", "32004499"]}, {"Citation": "den Besten G., Lange K., Havinga R., van Dijk T. H., Gerding A., van Eunen K., et al. . (2013a). Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G900\u2013G910. doi: 10.1152/ajpgi.00265.2013, PMID:", "ArticleIdList": ["10.1152/ajpgi.00265.2013", "24136789"]}, {"Citation": "den Besten G., van Eunen K., Groen A. K., Venema K., Reijngoud D. J., Bakker B. M. (2013b). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325\u20132340. doi: 10.1194/jlr.R036012, PMID:", "ArticleIdList": ["10.1194/jlr.R036012", "PMC3735932", "23821742"]}, {"Citation": "Dong W. W., Xuan F. L., Zhong F. L., Jiang J., Wu S., Li D., et al. . (2017). Comparative analysis of the rats\u2019 gut microbiota composition in animals with different ginsenosides metabolizing activity. J. Agric. Food Chem. 65, 327\u2013337. doi: 10.1021/acs.jafc.6b04848, PMID:", "ArticleIdList": ["10.1021/acs.jafc.6b04848", "28025886"]}, {"Citation": "Dunn W. B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., et al. . (2011). Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060\u20131083. doi: 10.1038/nprot.2011.335, PMID:", "ArticleIdList": ["10.1038/nprot.2011.335", "21720319"]}, {"Citation": "Edgar R. C. (2013). UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996\u2013998. doi: 10.1038/nmeth.2604", "ArticleIdList": ["10.1038/nmeth.2604", "23955772"]}, {"Citation": "El Kaoutari A., Armougom F., Gordon J. I., Raoult D., Henrissat B. (2013). The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11, 497\u2013504. doi: 10.1038/nrmicro3050", "ArticleIdList": ["10.1038/nrmicro3050", "23748339"]}, {"Citation": "Estes C., Anstee Q. M., Arias-Loste M. T., Bantel H., Bellentani S., Caballeria J., et al. . (2018). Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J. Hepatol. 69, 896\u2013904. doi: 10.1016/j.jhep.2018.05.036", "ArticleIdList": ["10.1016/j.jhep.2018.05.036", "29886156"]}, {"Citation": "Fan Y. (2018). Clinical research progress of Shenling Baizhu powder. J. New Chin. Med. 50, 38\u201342. doi: 10.13457/j.cnki.jncm.2018.10.010.Chinese", "ArticleIdList": ["10.13457/j.cnki.jncm.2018.10.010.Chinese"]}, {"Citation": "Fei Z., Qichang X., Ying W., Yu C., Chunchao Y., Chen Y. (2017). Effect of Dioscorea opposita thunb. Polysaccharide on glycolipid metabolism and oxidative stress in type 2 diabetic rats. Food Sci. 38, 262\u2013266. doi: 10.7506/spkx1002-6630-201705043.Chinese", "ArticleIdList": ["10.7506/spkx1002-6630-201705043.Chinese"]}, {"Citation": "Feng W., Liu J., Tan Y., Ao H., Wang J., Peng C. (2020). Polysaccharides from Atractylodes macrocephala Koidz. Ameliorate ulcerative colitis via extensive modification of gut microbiota and host metabolism. Food Res. Int. 138:109777. doi: 10.1016/j.foodres.2020.109777, PMID:", "ArticleIdList": ["10.1016/j.foodres.2020.109777", "33288163"]}, {"Citation": "Flint H. J., Duncan S. H., Scott K. P., Louis P. (2015). Links between diet, gut microbiota composition and gut metabolism. Proc. Nutr. Soc. 74, 13\u201322. doi: 10.1017/s0029665114001463", "ArticleIdList": ["10.1017/s0029665114001463", "25268552"]}, {"Citation": "Gika H. G., Theodoridis G. A., Earll M., Wilson I. D. (2012). A QC approach to the determination of day-to-day reproducibility and robustness of LC-MS methods for global metabolite profiling in metabonomics/metabolomics. Bioanalysis 4, 2239\u20132247. doi: 10.4155/bio.12.212, PMID:", "ArticleIdList": ["10.4155/bio.12.212", "23046266"]}, {"Citation": "Guarner F., Malagelada J. R. (2003). Gut flora in health and disease. Lancet 361, 512\u2013519. doi: 10.1016/s0140-6736(03)12489-0", "ArticleIdList": ["10.1016/s0140-6736(03)12489-0", "12583961"]}, {"Citation": "Guihong Z., Jianguang S., Yuli S., Zhen H. (2019). Discussion on etiology and pathogenesis of fatty liver in TCM from gasification. Asia-Pac. Tradit. Med. 15, 190\u2013191. doi: 10.11954/ytctyy.201905060.Chinese", "ArticleIdList": ["10.11954/ytctyy.201905060.Chinese"]}, {"Citation": "Haak B. W., Littmann E. R., Chaubard J. L., Pickard A. J., Fontana E., Adhi F., et al. . (2018). Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood 131, 2978\u20132986. doi: 10.1182/blood-2018-01-828996, PMID:", "ArticleIdList": ["10.1182/blood-2018-01-828996", "PMC6024637", "29674425"]}, {"Citation": "Haque T. R., Barritt A. S. (2016). Intestinal microbiota in liver disease. Best Pract. Res. Clin. Gastroenterol. 30, 133\u2013142. doi: 10.1016/j.bpg.2016.02.004", "ArticleIdList": ["10.1016/j.bpg.2016.02.004", "27048904"]}, {"Citation": "Hawley S. A., Gadalla A. E., Olsen G. S., Hardie D. G. (2002). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420\u20132425. doi: 10.2337/diabetes.51.8.2420", "ArticleIdList": ["10.2337/diabetes.51.8.2420", "12145153"]}, {"Citation": "He F. (2020). Effects of xylooligosaccharides on improving gestational diabetes mellitus by modulating gut microbiota. Jiangnan Univ. 284, 1362\u20131365. doi: 10.27169/d.cnki.gwqgu.2020.000091.Chinese", "ArticleIdList": ["10.27169/d.cnki.gwqgu.2020.000091.Chinese"]}, {"Citation": "Henningsson A. M., Nyman E. M., Bj\u00f6rck I. M. (2001). Content of short-chain fatty acids in the hindgut of rats fed processed bean (Phaseolus vulgaris) flours varying in distribution and content of indigestible carbohydrates. Br. J. Nutr. 86, 379\u2013389. doi: 10.1079/bjn2001423", "ArticleIdList": ["10.1079/bjn2001423", "11570990"]}, {"Citation": "Horton J. D., Goldstein J. L., Brown M. S. (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125\u20131131. doi: 10.1172/jci15593, PMID:", "ArticleIdList": ["10.1172/jci15593", "PMC150968", "11994399"]}, {"Citation": "Hu Y. (2015). Advantages and prospects of traditional Chinese medicine in treating nonalcoholic fatty liver disease. World Chin. Med. 10, 149\u2013152. doi: 10.3969/j.issn.1673-7202(sj).2015.02.002", "ArticleIdList": ["10.3969/j.issn.1673-7202(sj).2015.02.002"]}, {"Citation": "Hu Y., Peng J., Feng Q. (2011). The key target of Chinese medicine treatment on alcoholic and nonalcoholic fatty liver disease: the gut. Chin. J. Integr. Tradit. West. Med. 31, 1269\u20131272.Chinese. PMID:", "ArticleIdList": ["22013810"]}, {"Citation": "Hua Gang L. X. (2009). 86 cases of fatty liver treated with Shenling Baizhu powder plus and minus. CJGMCM 24, 1724\u20131725. doi: 10.3969/j.issn.1003-8914.2009.09.066.Chinese", "ArticleIdList": ["10.3969/j.issn.1003-8914.2009.09.066.Chinese"]}, {"Citation": "Iannucci L. F., Sun J., Singh B. K., Zhou J., Kaddai V. A., Lanni A., et al. . (2016). Short chain fatty acids induce UCP2-mediated autophagy in hepatic cells. Biochem. Biophys. Res. Commun. 480, 461\u2013467. doi: 10.1016/j.bbrc.2016.10.072, PMID:", "ArticleIdList": ["10.1016/j.bbrc.2016.10.072", "27773823"]}, {"Citation": "Idilman R., Mizrak D., Corapcioglu D., Bektas M., Doganay B., Sayki M., et al. . (2008). Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 28, 200\u2013208. doi: 10.1111/j.1365-2036.2008.03723.x, PMID:", "ArticleIdList": ["10.1111/j.1365-2036.2008.03723.x", "18445142"]}, {"Citation": "Jian\u2019gao Z. D. F. (2016). Effects of intestinal microbiota-SCFAs in metabolic diseases. Chin. J. Gastroenterol. Hepatol. 25, 330\u2013332. doi: 10.3969/j.issn.1006-5709.2016.03.026.Chinese", "ArticleIdList": ["10.3969/j.issn.1006-5709.2016.03.026.Chinese"]}, {"Citation": "Kechin A., Boyarskikh U., Kel A., Filipenko M. (2017). cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J. Comput. Biol. 24, 1138\u20131143. doi: 10.1089/cmb.2017.0096, PMID:", "ArticleIdList": ["10.1089/cmb.2017.0096", "28715235"]}, {"Citation": "Kim K. A., Yoo H. H., Gu W., Yu D. H., Jin M. J., Choi H. L., et al. . (2014). Effect of a soluble prebiotic fiber, NUTRIOSE, on the absorption of ginsenoside Rd in rats orally administered ginseng. J. Ginseng Res. 38, 203\u2013207. doi: 10.1016/j.jgr.2014.03.003, PMID:", "ArticleIdList": ["10.1016/j.jgr.2014.03.003", "PMC4213839", "25378995"]}, {"Citation": "Lee H., Ko G. (2014). Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80, 5935\u20135943. doi: 10.1128/aem.01357-14, PMID:", "ArticleIdList": ["10.1128/aem.01357-14", "PMC4178684", "25038099"]}, {"Citation": "Lee H., Lee Y., Kim J., An J., Lee S., Kong H., et al. . (2018). Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice. Gut Microbes 9, 155\u2013165. doi: 10.1080/19490976.2017.1405209, PMID:", "ArticleIdList": ["10.1080/19490976.2017.1405209", "PMC5989809", "29157127"]}, {"Citation": "Levy M., Thaiss C. A., Elinav E. (2016). Metabolites: messengers between the microbiota and the immune system. Genes Dev. 30, 1589\u20131597. doi: 10.1101/gad.284091.116, PMID:", "ArticleIdList": ["10.1101/gad.284091.116", "PMC4973288", "27474437"]}, {"Citation": "Li J., Zou B., Yeo Y. H., Feng Y., Xie X., Lee D. H., et al. . (2019). Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 4, 389\u2013398. doi: 10.1016/s2468-1253(19)30039-1", "ArticleIdList": ["10.1016/s2468-1253(19)30039-1", "30902670"]}, {"Citation": "Liang J.-L. (2017). Shenling Baizhu powder for the treatment of diseases related to intestinal flora dysbiosis. Asia-Pac. Tradit. Med. 13, 56\u201358. doi: 10.11954/ytctyy.201713023.Chinese", "ArticleIdList": ["10.11954/ytctyy.201713023.Chinese"]}, {"Citation": "Liu Y., Wan Q., Guan Q., Gao L., Zhao J. (2006). High-fat diet feeding impairs both the expression and activity of AMPKa in rats\u2019 skeletal muscle. Biochem. Biophys. Res. Commun. 339, 701\u2013707. doi: 10.1016/j.bbrc.2005.11.068", "ArticleIdList": ["10.1016/j.bbrc.2005.11.068", "16316631"]}, {"Citation": "Liu Y., Wang C., Li J., Li T., Zhang Y., Liang Y., et al. . (2020). Phellinus linteus polysaccharide extract improves insulin resistance by regulating gut microbiota composition. FASEB J. 34, 1065\u20131078. doi: 10.1096/fj.201901943RR, PMID:", "ArticleIdList": ["10.1096/fj.201901943RR", "31914668"]}, {"Citation": "Loke W. M., Proudfoot J. M., Stewart S., McKinley A. J., Needs P. W., Kroon P. A., et al. . (2008). Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem. Pharmacol. 75, 1045\u20131053. doi: 10.1016/j.bcp.2007.11.002, PMID:", "ArticleIdList": ["10.1016/j.bcp.2007.11.002", "18096136"]}, {"Citation": "Loomba R., Lutchman G., Kleiner D. E., Ricks M., Feld J. J., Borg B. B., et al. . (2009). Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 29, 172\u2013182. doi: 10.1111/j.1365-2036.2008.03869.x, PMID:", "ArticleIdList": ["10.1111/j.1365-2036.2008.03869.x", "PMC2990687", "18945255"]}, {"Citation": "Lotowska J. M., Sobaniec-Lotowska M. E., Bockowska S. B., Lebensztejn D. M. (2014). Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria. World J. Gastroenterol. 20, 4335\u20134340. doi: 10.3748/wjg.v20.i15.4335, PMID:", "ArticleIdList": ["10.3748/wjg.v20.i15.4335", "PMC3989968", "24764670"]}, {"Citation": "Luo J., Shen S., Xia J., Wang J., Gu Z. (2022). Mitochondria as the essence of Yang Qi in the human body. Phenomics 2, 336\u2013348. doi: 10.1007/s43657-022-00060-3, PMID:", "ArticleIdList": ["10.1007/s43657-022-00060-3", "PMC9590506", "36939762"]}, {"Citation": "Ma F., Zhang Y., Liu N., Zhang J., Tan G., Kannan B., et al. . (2017). Rheological properties of polysaccharides from Dioscorea opposita thunb. Food Chem. 227, 64\u201372. doi: 10.1016/j.foodchem.2017.01.072", "ArticleIdList": ["10.1016/j.foodchem.2017.01.072", "28274459"]}, {"Citation": "Makishima M., Okamoto A. Y., Repa J. J., Tu H., Learned R. M., Luk A., et al. . (1999). Identification of a nuclear receptor for bile acids. Science 284, 1362\u20131365. doi: 10.1126/science.284.5418.1362, PMID:", "ArticleIdList": ["10.1126/science.284.5418.1362", "10334992"]}, {"Citation": "McNeil N. I. (1984). The contribution of the large intestine to energy supplies in man. Am. J. Clin. Nutr. 39, 338\u2013342. doi: 10.1093/ajcn/39.2.338, PMID:", "ArticleIdList": ["10.1093/ajcn/39.2.338", "6320630"]}, {"Citation": "Miele L., Valenza V., La Torre G., Montalto M., Cammarota G., Ricci R., et al. . (2009). Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877\u20131887. doi: 10.1002/hep.22848, PMID:", "ArticleIdList": ["10.1002/hep.22848", "19291785"]}, {"Citation": "Mingbing C., Sheng X., Wenjie D., Juan L., Jianfeng L., Xiaoyan H., et al. . (2018). Applications and research progresses of Shenling Baizhu decoction in digestive system diseases. J. Liaoning Univ. Tradit. Chin. Med. 20, 164\u2013166. doi: 10.13194/j.issn.1673-842x.2018.10.042.Chinese", "ArticleIdList": ["10.13194/j.issn.1673-842x.2018.10.042.Chinese"]}, {"Citation": "Mnatsakanyan N., Jonas E. A. (2020). The new role of F1Fo ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection. Exp. Neurol. 332:113400. doi: 10.1016/j.expneurol.2020.113400, PMID:", "ArticleIdList": ["10.1016/j.expneurol.2020.113400", "PMC7877222", "32653453"]}, {"Citation": "Mortensen F. V., Nielsen H., Aalkjaer C., Mulvany M. J., Hessov I. (1994). Short chain fatty acids relax isolated resistance arteries from the human ileum by a mechanism dependent on anion-exchange. Pharmacol. Toxicol. 75, 181\u2013185. doi: 10.1111/j.1600-0773.1994.tb00344.x, PMID:", "ArticleIdList": ["10.1111/j.1600-0773.1994.tb00344.x", "7800661"]}, {"Citation": "Murag S., Ahmed A., Kim D. (2021). Recent epidemiology of nonalcoholic fatty liver disease. Gut Liver 15, 206\u2013216. doi: 10.5009/gnl20127, PMID:", "ArticleIdList": ["10.5009/gnl20127", "PMC7960978", "32921636"]}, {"Citation": "Murphy E. F., Cotter P. D., Healy S., Marques T. M., O\u2019Sullivan O., Fouhy F., et al. . (2010). Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59, 1635\u20131642. doi: 10.1136/gut.2010.215665", "ArticleIdList": ["10.1136/gut.2010.215665", "20926643"]}, {"Citation": "Pan M. X., Zheng C. Y., Deng Y. J., Tang K. R., Nie H., Xie J. Q., et al. . (2021). Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease. J. Integr. Med. 19, 428\u2013438. doi: 10.1016/j.joim.2021.07.004, PMID:", "ArticleIdList": ["10.1016/j.joim.2021.07.004", "34426178"]}, {"Citation": "Parks D. J., Blanchard S. G., Bledsoe R. K., Chandra G., Consler T. G., Kliewer S. A., et al. . (1999). Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365\u20131368. doi: 10.1126/science.284.5418.1365, PMID:", "ArticleIdList": ["10.1126/science.284.5418.1365", "10334993"]}, {"Citation": "Peng L., Zhang Q., Zhang Y., Yao Z., Song P., Wei L., et al. . (2020). Effect of tartary buckwheat, rutin, and quercetin on lipid metabolism in rats during high dietary fat intake. Food Sci. Nutr. 8, 199\u2013213. doi: 10.1002/fsn3.1291, PMID:", "ArticleIdList": ["10.1002/fsn3.1291", "PMC6977491", "31993146"]}, {"Citation": "Porras D., Nistal E., Mart\u00ednez-Fl\u00f3rez S., Pisonero-Vaquero S., Olcoz J. L., Jover R., et al. . (2017). Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radic. Biol. Med. 102, 188\u2013202. doi: 10.1016/j.freeradbiomed.2016.11.037, PMID:", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.11.037", "27890642"]}, {"Citation": "Porras-Sanabria D., Garc\u00eda-Mediavilla M., Mart\u00ednez-Fl\u00f3rez S., Nistal E., Olcoz J., Jover R., et al. . (2016). Modulation of intestinal microbiota and gut-liver axis by quercetin improve HFD-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. J. Hepatol. 64:S677. doi: 10.1016/S0168-8278(16)01282-4", "ArticleIdList": ["10.1016/S0168-8278(16)01282-4"]}, {"Citation": "Qi D., Si-wen F., Gong-hao X., Ye-yang C., Yuan-yuan S. (2022). Effects of the total ginsenosides from Panax ginseng stems and leaves on gut microbiota and short-chain fatty acids metabolism in acute lung injury mice. China J. Chin. Mater. Med. 48, 1319\u20131329. doi: 10.19540/j.cnki.cjcmm.20221111.702.Chinese", "ArticleIdList": ["10.19540/j.cnki.cjcmm.20221111.702.Chinese", "37005816"]}, {"Citation": "Qiyu G., Yingzheng Z., Lingbo Z., Guangcui X. (2015). The influence of Chinese yam polysaccharide on growth performance and intestinal micro flora in Konmin mice. Chin. J. Gerontol. 35, 5685\u20135687. doi: 10.3969/j.issn.1005-9202.2015.20.003.Chinese", "ArticleIdList": ["10.3969/j.issn.1005-9202.2015.20.003.Chinese"]}, {"Citation": "Rao K., Qin S., Yang Y., Zhan K., Wu H., Zheng H., et al. . (2022). Shenling Baizhu powder alleviates tnbs-induced colitis in rats by improving intestinal epithelial permeability and inhibiting inflammation through the TLR5/MyD88/NF-\u03baB pathway. Front. Pharmacol. 13:883918. doi: 10.3389/fphar.2022.883918, PMID:", "ArticleIdList": ["10.3389/fphar.2022.883918", "PMC9096158", "35571126"]}, {"Citation": "Ryan P. M., Patterson E., Carafa I., Mandal R., Wishart D. S., Dinan T. G., et al. . (2020). Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice. Can. J. Diabetes 44, 146\u2013155.e2. doi: 10.1016/j.jcjd.2019.05.008", "ArticleIdList": ["10.1016/j.jcjd.2019.05.008", "31445961"]}, {"Citation": "Samari H. R., M\u00f8ller M. T., Holden L., Asmyhr T., Seglen P. O. (2005). Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins. Biochem. J. 386, 237\u2013244. doi: 10.1042/bj20040609, PMID:", "ArticleIdList": ["10.1042/bj20040609", "PMC1134787", "15461583"]}, {"Citation": "Sanyal A. J. (2019). Past, present and future perspectives in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 16, 377\u2013386. doi: 10.1038/s41575-019-0144-8, PMID:", "ArticleIdList": ["10.1038/s41575-019-0144-8", "31024089"]}, {"Citation": "Savkur R. S., Bramlett K. S., Michael L. F., Burris T. P. (2005). Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor. Biochem. Biophys. Res. Commun. 329, 391\u2013396. doi: 10.1016/j.bbrc.2005.01.141, PMID:", "ArticleIdList": ["10.1016/j.bbrc.2005.01.141", "15721319"]}, {"Citation": "Schwiertz A., Taras D., Sch\u00e4fer K., Beijer S., Bos N. A., Donus C., et al. . (2010). Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190\u2013195. doi: 10.1038/oby.2009.167, PMID:", "ArticleIdList": ["10.1038/oby.2009.167", "19498350"]}, {"Citation": "Shi Y., Lian Y., Zhai M., Jin S., Sun W., Shoujun L., et al. . (2016). Effect of nano Chinese yam polysaccharide on 4 kinds of tumor cells. Chin. J. Mod. Appl. Pharm. 33, 967\u2013971. doi: 10.13748/j.cnki.issn1007-7693.2016.08.001", "ArticleIdList": ["10.13748/j.cnki.issn1007-7693.2016.08.001"]}, {"Citation": "Skuratovskaia D., Komar A., Vulf M., Quang H. V., Shunkin E., Volkova L., et al. . (2021). IL-6 reduces mitochondrial replication, and IL-6 receptors reduce chronic inflammation in NAFLD and type 2 diabetes. Int. J. Mol. Sci. 22:1774. doi: 10.3390/ijms22041774, PMID:", "ArticleIdList": ["10.3390/ijms22041774", "PMC7916777", "33579000"]}, {"Citation": "Song K., Jiang Z., Yan Q., Chen C., Shi S. (2011). Experimental study on the effect of radix codonopsis and poria on intestinal flora in mice. Chin. J. Clin. Pharmacol. 27, 142\u2013145. doi: 10.13699/j.cnki.1001-6821.2011.02.003.Chinese", "ArticleIdList": ["10.13699/j.cnki.1001-6821.2011.02.003.Chinese"]}, {"Citation": "Stepensky D., Friedman M., Raz I., Hoffman A. (2002). Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect. Drug Metab. Dispos. 30, 861\u2013868. doi: 10.1124/dmd.30.8.861, PMID:", "ArticleIdList": ["10.1124/dmd.30.8.861", "12124302"]}, {"Citation": "Tang K., Deng Y., Zheng C., Nie H., Pan M., Chen R., et al. . (2020). Prevention of nonalcoholic hepatic steatosis by Shenling Baizhu powder: involvement of adiponectin-induced inhibition of hepatic SREBP-1c. Oxid. Med. Cell Longev. 2020, 9701285\u20139701213. doi: 10.1155/2020/9701285, PMID:", "ArticleIdList": ["10.1155/2020/9701285", "PMC7533788", "33062150"]}, {"Citation": "Vancura A., Nagar S., Kaur P., Bu P., Bhagwat M., Vancurova I. (2018). Reciprocal regulation of AMPK/SNF1 and protein acetylation. Int. J. Mol. Sci. 19:3314. doi: 10.3390/ijms19113314, PMID:", "ArticleIdList": ["10.3390/ijms19113314", "PMC6274705", "30366365"]}, {"Citation": "Vanni E., Bugianesi E. (2009). The gut-liver axis in nonalcoholic fatty liver disease: another pathway to insulin resistance? Hepatology 49, 1790\u20131792. doi: 10.1002/hep.23036", "ArticleIdList": ["10.1002/hep.23036", "19475679"]}, {"Citation": "Vinolo M. A., Rodrigues H. G., Hatanaka E., Sato F. T., Sampaio S. C., Curi R. (2011). Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22, 849\u2013855. doi: 10.1016/j.jnutbio.2010.07.009, PMID:", "ArticleIdList": ["10.1016/j.jnutbio.2010.07.009", "21167700"]}, {"Citation": "Wang H., Chen J., Hollister K., Sowers L. C., Forman B. M. (1999). Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3, 543\u2013553. doi: 10.1016/s1097-2765(00)80348-2, PMID:", "ArticleIdList": ["10.1016/s1097-2765(00)80348-2", "10360171"]}, {"Citation": "Wang S., Huang X-F., Yin W., Han Y., Wang R-A., Li Z-S., et al. . (2012). Ultrastructural features of liver tissues in non-alcoholic fatty liver disease. Prog. Mod. Biomed., 12, 2703\u20132705. doi: 10.13241/j.cnki.pmb.2012.14.029 (in Chinese)", "ArticleIdList": ["10.13241/j.cnki.pmb.2012.14.029"]}, {"Citation": "Wang Z., Klipfell E., Bennett B. J., Koeth R., Levison B. S., Dugar B., et al. . (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363. doi: 10.1038/nature09922, PMID:", "ArticleIdList": ["10.1038/nature09922", "PMC3086762", "21475195"]}, {"Citation": "Wang X., Huo X.-z., Liu Z., Yang R., Zeng H.-j. (2020). Investigations on the anti-aging activity of polysaccharides from Chinese yam and their regulation on klotho gene expression in mice. J. Mol. Struct. 1208:127895. doi: 10.1016/j.molstruc.2020.127895", "ArticleIdList": ["10.1016/j.molstruc.2020.127895"]}, {"Citation": "Wang Yan H. D., Zhijun L. (2013). AMPK regulate mitochondrial function. Chin. J. Cell Biol. 35, 1434\u20131443. doi: 10.11844/cjcb.2013.10.0159.Chinese", "ArticleIdList": ["10.11844/cjcb.2013.10.0159.Chinese"]}, {"Citation": "Wang R., Zhou G., Wang M., Peng Y., Li X. (2014). The metabolism of polysaccharide from Atractylodes macrocephala Koidz and its rffect on intestinal microflora. Evid. Based Complement. Alternat. Med. 2014:926381. doi: 10.1155/2014/926381, PMID:", "ArticleIdList": ["10.1155/2014/926381", "PMC4258363", "25505927"]}, {"Citation": "Wei X., He Y., Jiang L. (2006a). The study of the antibacterial activity in vitro and determination of flavones of Flos Paulowniae. Nat. Prod. Res. Dev. 18:401. doi: 10.16333/j.1001-6880.2006.03.011.Chinese", "ArticleIdList": ["10.16333/j.1001-6880.2006.03.011.Chinese"]}, {"Citation": "Wei L., Hongmei W., Xiaobing C., Xuan L., Min H. (2006b). Study on the effective components of Atractylodes macrocephala for strengthening the spleen. J. Nanjing TCM Univ. 06, 366\u2013367. doi: 10.3969/j.issn.1000-5005.2006.06.009.Chinese", "ArticleIdList": ["10.3969/j.issn.1000-5005.2006.06.009.Chinese"]}, {"Citation": "Wei Jitong Y. X. (2011). The efficacy of Shenling Baizhu powder plus and minus in treating 60 cases of non-alcoholic fatty liver. J. Jiujiang Univ. 26, 59\u201360. doi: 10.19717/j.cnki.jjun.2011.04.020.Chinese", "ArticleIdList": ["10.19717/j.cnki.jjun.2011.04.020.Chinese"]}, {"Citation": "Wen-wu H., Ying P., Meng-yue W., Chong-sheng P., Xiao-bo L. (2019). Regulatory effect of Sijunzi Tang and its single herbs on intestinal flora in rats with spleen deficiency. Chin. J. Exp. Tradit. Med. Formulae 25, 8\u201315. doi: 10.13422/j.cnki.syfjx.20190847.Chinese", "ArticleIdList": ["10.13422/j.cnki.syfjx.20190847.Chinese"]}, {"Citation": "Wieckowski M. R., Giorgi C., Lebiedzinska M., Duszynski J., Pinton P. (2009). Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc. 4, 1582\u20131590. doi: 10.1038/nprot.2009.151", "ArticleIdList": ["10.1038/nprot.2009.151", "19816421"]}, {"Citation": "Wong V. W., Chan W. K., Chitturi S., Chawla Y., Dan Y. Y., Duseja A., et al. . (2018). Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J. Gastroenterol. Hepatol. 33, 70\u201385. doi: 10.1111/jgh.13857", "ArticleIdList": ["10.1111/jgh.13857", "28670712"]}, {"Citation": "Xianzhao W., Chan W. K., Chitturi S., Chawla Y., Dan Y. Y., Duseja A., et al. . (2017). Effect of Shenling Baizhu San on nonalcoholic fatty liver disease:a meta-analysis of randomized controlled trials. J. Liaoning Univ. TCM 19, 110\u2013114. doi: 10.13194/j.issn.1673-842x.2017.09.030.Chinese", "ArticleIdList": ["10.13194/j.issn.1673-842x.2017.09.030.Chinese"]}, {"Citation": "Xiao Y., Zhang K., Zhu S. Y., Deng X. L., Chen X. Y., Fu N. L., et al. . (2021). Shenling Baizhu powder () ameliorates pi (spleen)-deficiency-induced functional diarrhea in rats. Chin. J. Integr. Med. 27, 206\u2013211. doi: 10.1007/s11655-020-3259-4, PMID:", "ArticleIdList": ["10.1007/s11655-020-3259-4", "32720115"]}, {"Citation": "Xiaodong D. (2002). Mitochondrial dysfunction and obese fatty liver. Foreign Med. 01, 42\u201344. doi: 10.3969/j.issn.1673-534X.2002.01.016.Chinese", "ArticleIdList": ["10.3969/j.issn.1673-534X.2002.01.016.Chinese"]}, {"Citation": "Xiong Y., Miyamoto N., Shibata K., Valasek M. A., Motoike T., Kedzierski R. M., et al. . (2004). Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. U. S. A. 101, 1045\u20131050. doi: 10.1073/pnas.2637002100, PMID:", "ArticleIdList": ["10.1073/pnas.2637002100", "PMC327148", "14722361"]}, {"Citation": "Xiuwen W. (2017). Intestinal flora and mitochondrial crosstalk. Parenter. Enter. Nutr. 24, 328\u2013331. doi: 10.16151/j.1007-810x.2017.06.003.Chinese", "ArticleIdList": ["10.16151/j.1007-810x.2017.06.003.Chinese"]}, {"Citation": "Yang Yinhua W. J.-N., Xue H., et al. . (2015). Blood rheological changes in rats with early stage non-alcoholic fatty liver disease and the interventional effect of diaphragmatic discharge of blood stasis soup. China Prac. Med. 10, 278\u2013279. doi: 10.14163/j.cnki.11-5547/r.2015.05.200.Chinese", "ArticleIdList": ["10.14163/j.cnki.11-5547/r.2015.05.200.Chinese"]}, {"Citation": "Yanning H. Y. (2017). Ideas and methods in prevention and treatment of chronic liver disease with TCM liver and spleen related theory. Acta Chin. Med. 32, 1206\u20131208. doi: 10.16368/j.issn.1674-8999.2017.07.317.Chinese", "ArticleIdList": ["10.16368/j.issn.1674-8999.2017.07.317.Chinese"]}, {"Citation": "Yao Z., Wang J. N., Chen R., et al. . (2017). Dynamic observation of the effect of adding flavor Er Chen Tang on UCP2 in rats with non-alcoholic fatty liver. Lishizhen Med. Mater. Med. Res. 28, 2589\u20132591. doi: 10.3969/j.issn.1008-0805.2017.11.010.Chinese", "ArticleIdList": ["10.3969/j.issn.1008-0805.2017.11.010.Chinese"]}, {"Citation": "Yue-qiao S. Q. (2012). Clinical observation of nonalcoholic fatty liver disease treated with modified Shenling Baizhu San decoction. J. Liaoning Univ. TCM 14, 180\u2013181. doi: 10.13194/j.jlunivtcm.2012.09.182.shiql.023.Chinese", "ArticleIdList": ["10.13194/j.jlunivtcm.2012.09.182.shiql.023.Chinese"]}, {"Citation": "Zhang N., Liang T., Jin Q., Shen C., Zhang Y., Jing P. (2019). Chinese yam (Dioscorea opposita Thunb.) alleviates antibiotic-associated diarrhea, modifies intestinal microbiota, and increases the level of short-chain fatty acids in mice. Food Res. Int. 122, 191\u2013198. doi: 10.1016/j.foodres.2019.04.016, PMID:", "ArticleIdList": ["10.1016/j.foodres.2019.04.016", "31229072"]}, {"Citation": "Zhang S., Shi A., Bian Y. (2015). Influence of Quzhi Ruangan formula on blood fat and hemorheology of rats with early. Chin. J. Tradit. Chin. Med. Pharm. 30:875\u2013877."}, {"Citation": "Zhang Shunzhen J. Z., Zheng Y., et al. . (2015). Exploring the treatment of nonalcoholic fatty liver from the phlegm-stasis theory. Yunnan J. Tradit. Chin. Med. Mater. Med. 36, 21\u201323. doi: 10.16254/j.cnki.53-1120/r.2015.06.009.Chinese", "ArticleIdList": ["10.16254/j.cnki.53-1120/r.2015.06.009.Chinese"]}, {"Citation": "Zhang Y., Tang K., Deng Y., Chen R., Liang S., Xie H., et al. . (2018). Effects of Shenling Baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. Biomed. Pharmacother. 102, 1025\u20131036. doi: 10.1016/j.biopha.2018.03.158", "ArticleIdList": ["10.1016/j.biopha.2018.03.158", "29710519"]}, {"Citation": "Zhang W., Xu J. H., Yu T., Chen Q. K. (2019). Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. Biomed. Pharmacother. 118:109131. doi: 10.1016/j.biopha.2019.109131, PMID:", "ArticleIdList": ["10.1016/j.biopha.2019.109131", "31545226"]}, {"Citation": "Zhao L., Zhang F., Ding X., Wu G., Lam Y. Y., Wang X., et al. . (2018). Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151\u20131156. doi: 10.1126/science.aao5774, PMID:", "ArticleIdList": ["10.1126/science.aao5774", "29590046"]}, {"Citation": "Zhenhua L. Z. (2016). Effect of compound zhajin granules on lipid metabolism and liver cell ultrastructure of nonalcoholic fatty liver rats. Chin. Arch. Tradit. Chin. Med. 34, 1176\u20131179. doi: 10.13193/j.issn.1673-7717.2016.05.044.Chinese", "ArticleIdList": ["10.13193/j.issn.1673-7717.2016.05.044.Chinese"]}, {"Citation": "Zhou S., Huang G., Chen G. (2021). Extraction, structural analysis, derivatization and antioxidant activity of polysaccharide from Chinese yam. Food Chem. 361:130089. doi: 10.1016/j.foodchem.2021.130089, PMID:", "ArticleIdList": ["10.1016/j.foodchem.2021.130089", "34029907"]}, {"Citation": "Zhou J., Zhou F., Wang W., Zhang X. J., Ji Y. X., Zhang P., et al. . (2020). Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology 71, 1851\u20131864. doi: 10.1002/hep.31150", "ArticleIdList": ["10.1002/hep.31150", "32012320"]}, {"Citation": "Zhu J. Z., Zhou Q. Y., Wang Y. M., Dai Y. N., Zhu J., Yu C. H., et al. . (2015). Prevalence of fatty liver disease and the economy in China: a systematic review. World J. Gastroenterol. 21, 5695\u20135706. doi: 10.3748/wjg.v21.i18.5695, PMID:", "ArticleIdList": ["10.3748/wjg.v21.i18.5695", "PMC4427696", "25987797"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "18"}, {"Year": "2023", "Month": "6", "Day": "30"}, {"Year": "2023", "Month": "8", "Day": "4", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "8", "Day": "4", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "4", "Hour": "4", "Minute": "6"}, {"Year": "2023", "Month": "7", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["37538846", "PMC10394096", "10.3389/fmicb.2023.1147067"]}}], "PubmedBookArticle": []}